What is Mesenteric Panniculitis?
Mesenteric panniculitis is a benign chronic inflammatory and fibrotic condition affecting the adipose tissue of the small bowel mesentery that is usually discovered incidentally on CT imaging and requires no treatment in asymptomatic patients 1.
Clinical Presentation
The condition presents across a spectrum:
- Asymptomatic in up to 50% of cases - discovered incidentally on abdominal CT performed for other reasons 1
- When symptomatic, the most common complaint is abdominal pain, followed by bloating/distention, diarrhea, constipation, vomiting, anorexia, weight loss, fever, and nausea 1, 2
- Predominantly affects older adults (mean age ~70 years) with equal sex distribution 3
Diagnostic Approach
CT with IV contrast is the diagnostic modality of choice 1, 4. The characteristic imaging findings include:
- "Misty mesentery" appearance - a mass-like area of increased fat attenuation within the small bowel mesentery, typically in the left upper quadrant 1, 2
- The mass envelops mesenteric vessels and displaces adjacent bowel segments
- "Fat ring sign" - normal fat preserved around vessels and lymph nodes 5
- Lymph nodes frequently visible within the abnormal mesenteric area
- Pseudocapsule may be present around the lesion 5
Critical differential diagnosis: Lymphoma is the most important condition to exclude. If there is suspicion of underlying malignancy, obtain PET/CT and check tumor markers 1, 6.
Biopsy is NOT routinely needed if imaging is characteristic and the patient is asymptomatic with normal tumor markers 6.
Management Algorithm
For Asymptomatic Patients (31-50% of cases):
No treatment is required 6, 3. Instead:
- Annual follow-up with CT scan and tumor markers 6
- Reassure the patient about the benign nature of the condition
- 85.6% of patients remain clinically stable over time 3
For Symptomatic Patients:
First-line treatment: Prednisone 1, 4
- Patients on prednisone show good clinical and radiological responses during follow-up 4
- Symptom relief typically occurs within 72 hours 2
- Continue until symptoms resolve, then taper
Second-line options if prednisone fails or is not tolerated:
Surgery is reserved ONLY for recurrent bowel obstruction 1. Medical therapy failure alone is not an indication for surgery, as one study showed a patient who underwent surgery without responding to medical therapy had poor outcomes 4.
Important Caveats
- This is NOT the same as panniculitis associated with alpha-1 antitrypsin deficiency, which is a necrotizing skin condition affecting subcutaneous tissue of thighs/buttocks and requires different management 7
- The condition can be classified as primary (61.3%) or secondary when associated with malignancy, autoimmune disease, or infection (38.7%) 3
- Overall mortality is low (8.1%), slightly higher in secondary forms associated with neoplasms 3
- The generally indolent course means aggressive intervention is rarely warranted
Bottom line: If found incidentally and asymptomatic, observe annually. If symptomatic, treat with prednisone. Avoid surgery unless there is recurrent bowel obstruction.